Human liver microsomal thiol methyltransferase: inhibition by arylalkylamines

Abstract

1. Thiol methyltransferase (TMT) is a microsomal enzyme catalyzing the S-methylation of aliphatic sulphydryl drugs and xenobiotics. Studies of the functional significance of S-methylation catalysed by TMT have been hampered by lack of a potent, relatively specific, non-toxic inhibitor of the enzyme.

2. Human hepatic microsomal TMT was inhibited by the arylalkylamine 2,3-dichloro-α;-methylbenzylamine (DCMB), and by a series of arylalkylamines, as well as the arylamme, aniline.

3. Inhibition kinetic studies with DCMB, benzylamine, aniline, phenylethylamine and phenylethanolamine, five compounds with a wide range of IC₅₀ values, showed ‘mixed’ inhibition of TMT with respect to the methyl acceptor substrate, 2-mercaptoethanol. K_is and K_ii values were, respectively, 1.1 and 0.29 μM for DCMB, 160 μM each for benzylamine, 680 and 370 μM for aniline, 1640 and 1380 μM for phenylethylamine, and 2300 and 1400 μM for phenylethanolamine. Inhibition was at least partially reversible.

4. H.p.l.c. analyses were carried out with the products of enzyme reactions performed in the presence of aniline, benzylamine, and phenylethylamine to ascertain whether these compounds inhibited TMT by acting as methyl acceptors. Results showed that they did not act as methyl acceptor substrates.